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Coal miners are commonly exposed to coal
dust (CD) and polycyclic aromatic hydro-
carbons (PAHs). The CD originates within
the mine, whereas the PAHs are components
of occupational and avocational exposures
such as diesel engine exhaust and cigarette
smoke. The CD exposure can cause coal
workers’ pneumoconiosis, a disease of coal
miners characterized by the aggregation of
dust-laden macrophages near the respiratory
bronchioles to form structures known as mac-
ules. Inflammation is a consistent feature of
the pulmonary response to respirable CD
(Ghanem et al. 2004; Rom et al. 1987).
Although chronic inflammation is increasingly
believed to play a role in carcinogenesis in
many tissues (Marx 2004), the role of particle-
induced inflammation in pulmonary carcino-
genesis, the influence of particle-induced
inflammation on the metabolism of PAHs
and other known carcinogens, and the
histopathologic alterations produced by com-
bined exposure to CD and PAHs remain
incompletely investigated.
PAHs are metabolized to reactive inter-
mediates by cytochrome P450 1 (CYP1) gene
products. Recently, our laboratory has demon-
strated that respirable CD inhibits PAH-
induced CYP1A1 activity in the lung of rats.
The down-regulation of CYP1A1 induction
was associated with inflammation (Ghanem
et al. 2004). This information suggests that
CD may modify the metabolism of PAHs in
the lung. However, molecular changes that are
associated with CD exposure and resulting
pulmonary inflammation and down-regulation
of CYP1A1 induction have not yet been iden-
tified. In an experimental model of another
pneumoconiosis, silicosis, caspase inhibition
with resulting apoptosis down-regulation
reduces silica-induced inflammation (Borges
et al. 2002). Caspases play an important role in
both the intrinsic and extrinsic apoptotic path-
ways (Droin and Green 2004), making their
inhibition an elegant tool for investigating the
overall role of caspase-dependent apoptosis in
the pneumoconioses (Borges et al. 2002).
Because apoptosis is believed to play an essen-
tial role in the inflammation associated with
one pneumoconiosis, acute silicosis, and
because inflammation increased as CYP1A1
activity decreased in the rat model of coal
workers’ pneumoconiosis (Ghanem et al.
2004), we investigated the hypothesis that
apoptosis plays a critical role in lung injury and
down-regulation of CYP1A1 induction in
mixed exposures to CD and the model PAH
β-naphthoflavone (BNF).
Materials and Methods
Animals .  Male Sprague-Dawley rats
[Hla(SD)CVF] were purchased from Hilltop
Labs (Scottdale, PA) and kept in a barrier ani-
mal facility approved by the Association for
Assessment and Accreditation of Laboratory
Animal Care International. Food and water
were supplied ad libitum. Rats were housed in
ventilated shoebox cages on autoclaved hard-
wood (Beta-Chip; Northeastern Products
Inc., Warrensburg, NY) and cellulose bedding
(ALPHA-dri; Shepherd Specialty Papers,
Watertown, TN) in filtered, ventilated cage
racks (Thoren Caging System Inc., Hazleton,
PA). Rats were acclimatized for 1 week before
experiments. The animals were treated
humanely and with regard for alleviation of
suffering. The experimental protocol was
reviewed and approved by the Institutional
Animal Care and Use Committee.
Experimental design. We conducted two
separate experiments as part of this study. The
first experiment was a 2-week CD dose–
response experiment, in which we randomized
40 male Sprague-Dawley rats (220–270 g body
weight at time of exposure) into five groups
(eight rats per group) using a JavaScript ran-
dom-number–generating program (Research
Randomizer; Urbaniak and Plous 2003). We
intratracheally (IT) instilled 0.0, 2.5, 10.0,
20.0, or 40.0 mg/rat CD suspended in sterile
saline to model CD exposures of coal miners
as revealed in autopsy studies (Douglas et al.
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Apoptosis and Bax Expression are Increased by Coal Dust in the Polycyclic
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BACKGROUND: Miners inhaling respirable coal dust (CD) frequently develop coal workers’
pneumoconiosis, a dust-associated pneumoconiosis characterized by lung inflammation and vari-
able fibrosis. Many coal miners are also exposed to polycyclic aromatic hydrocarbon (PAH) compo-
nents of diesel engine exhaust and cigarette smoke, which may contribute to lung disease in these
workers. Recently, apoptosis was reported to play a critical role in the development of another
pneumoconiosis of miners, silicosis. In addition, CD was reported to suppress cytochrome
P450 1A1 (CYP1A1) induction by PAHs. 
METHODS: We investigated the hypothesis that apoptosis plays a critical role in lung injury and
down-regulation of CYP1A1 induction in mixed exposures to CD and PAHs. We exposed rats
intratracheally to 0.0, 2.5, 10.0, 20.0, or 40.0 mg/rat CD and, 11 days later, to intraperitoneal
β-naphthoflavone (BNF), a PAH. In another group of rats exposed to CD and BNF, caspase
activity was inhibited by injection of the pan-caspase inhibitor Q-VD-OPH [quinoline-Val-Asp
(OMe)-CH2-OPH]. 
RESULTS: In rats exposed to BNF, CD exposure increased alveolar expression of the proapoptotic
mediator Bax but decreased CYP1A1 induction relative to BNF exposure alone. Pan-caspase inhibi-
tion decreased CD-associated Bax expression and apoptosis but did not restore CYP1A1 activity.
Further, CD-induced lung inflammation and alveolar epithelial cell hypertrophy and hyperplasia
were not suppressed by caspase inhibition. 
CONCLUSIONS: Combined BNF and CD exposure increased Bax expression and apoptosis in the
lung, but Bax and apoptosis were not the major determinants of early lung injury in this model. 
KEY WORDS: apoptosis, Bax, caspase, coal dust, CYP1A1, CYP2B1, modifiers, polycyclic aromatic
hydrocarbons, pneumoconiosis, xenobiotic metabolism. Environ Health Perspect 114:1367–1373
(2006). doi:10.1289/ehp.8906 available via http://dx.doi.org/ [Online 18 May 2006]
1986; Kuempel et al. 2001). Eleven days later,
we intraperitoneally (IP) injected the classic
CYP1A1 inducer BNF (50 mg/kg) in all rats
to model the PAH-exposed lung. Two weeks
after CD exposure, rats were euthanized by an
overdose of sodium pentobarbital. This experi-
ment determined the relationship between
CD exposure and expression of the apoptosis
mediator Bax. This study also localized Bax
expression relative to the expression of
CYP1A1 and cytokeratin 8/18, an alveolar
type II cell marker.
The second experiment was designed to
inhibit apoptosis in rats exposed to CD and
BNF. In this experiment, we randomized
24 male Sprague-Dawley rats (67–93 g body
weight at time of exposure) into four groups
(Table 1). We instilled each rat IT with either
CD (40 mg/rat) suspended in 0.3 mL saline
or saline alone (controls). To inhibit apopto-
sis, we injected the rats IP with the caspase
inhibitor Q-VD-OPH [quinoline-Val-
Asp(OMe)-CH2-OPH; 15 mg/kg] dissolved
in the vehicle [dimethylsulfoxide (DMSO)] or
the vehicle alone (controls) on the day of CD
exposure. We injected 10 mg/kg Q-VD-OPH
on days 5, 9, 10, 11, 12, and 13 postexposure
to maintain caspase inhibition, whereas con-
trols received injections of the vehicle. Eleven
days after CD exposure, we induced CYP1A1
in all rats by IP injection of BNF (50 mg/kg)
in corn oil. This allowed us to determine if
apoptosis was etiologically associated with
lung changes seen in CD-exposed rats, includ-
ing a) suppression of CYP1A1 activity and
CYP1A1 tissue expression, b) suppression of
CYP2B1 activity, and c) histopathologic alter-
ations in lung tissue. In addition, we evaluated
Bax expression and apoptosis to determine the
efficacy of in vivo caspase inhibition with
Q-VD-OPH.
Preparation of CD suspension. CD particles
from the Pittsburgh coal seam were a generous
gift from V. Vallyathan (National Institute for
Occupational Safety and Health). These were
separated and characterized as previously
described (Vallyathan et al. 1988). The particles
were representative low-silica–content CD par-
ticles, with 2.3% of the particles numerically
being silica. The CD particles were < 5 µm in
diameter with a surface area of 7.4 m2/g and a
mass median aerodynamic diameter of 3.4 µm.
The particles contained 0.34% total iron with a
0.119% surface iron content. We sterilized the
particles in an oven at 160°C for 2 hr. We
freshly suspended the sterile CD particles in
nonpyrogenic sterile 0.9% saline (Abbott
Laboratories, North Chicago, IL) by vortexing
and shaking before instillation.
Preparation of apoptosis inhibitor Q-VD-
OPH. We prepared solutions of 2% (wt/wt)
Q-VD-OPH (Enzyme Systems Products Inc.,
Livermore, CA) in endotoxin-free DMSO
(Sigma Chemical Co., St. Louis, MO).
Preparation of BNF. We prepared a
50 mg/mL suspension of BNF (Sigma-Aldrich,
St. Louis, MO) as previously described
(Ghanem et al. 2004).
Necropsy of rats. Rats were euthanized by
IP injection of sodium pentobarbital
(≥ 100 mg/kg) (Sleepaway; Fort Dodge
Animal Health, Fort Dodge, IA) 2 weeks after
CD instillation. The right mainstem bronchus
was ligated, and right lung lobes were col-
lected and immediately placed on ice for isola-
tion of microsomes. The left lung lobe was
inflated with 3.0 mL of 10% neutral buffered
formalin, trimmed the same day, processed in
a tissue processor overnight, and embedded in
paraffin the following morning.
Measurement of CYP1A1 and CYP2B1
protein and activity. Microsomes were pre-
pared as previously described (Ma et al.
2002). We measured 7-ethoxyresorufin-O-
deethylase (EROD) and 7-pentoxyresorufin-
O-deethylase (PROD) activities as previously
described (Burke et al. 1985; Ma et al. 2002).
We conducted lung microsome Western blots
as previously described (Ghanem et al. 2004)
with minor adaptation by using a 15-well
Novex tris glycine gel (Invitrogen Life
Technologies, Carlsbad, CA) and 30 µg pro-
tein. Densitometry values were expressed as
the percentage of the CYP1A1- or CYP2B1-
positive controls.
Bax immunofluorescence. We deparaf-
finized lung sections and blocked nonspecific
binding as previously described (Ghanem et al.
2004). We rinsed the slides with distilled water
and incubated them with a 1:20 dilution of
affinity-purified polyclonal rabbit anti-Bax
antibody (sc-526; Santa Cruz Biotechnology
Inc., Santa Cruz, CA) overnight at room tem-
perature followed by 2 hr at 37°C. Alexa
594-conjugated goat anti-rabbit antibody
(Molecular Probes, Eugene, OR) was the sec-
ondary antibody. Nonimmune rabbit serum
(BioGenex, San Ramon, CA) was used for the
negative control.
Immunofluorescence for CYP1A1 and
cytokeratin 8/18. We conducted double-label
immunofluorescence for localization of
CYP1A1 and cytokeratin 8/18 as previously
described (Ghanem et al. 2004).
Triple-label immunofluorescence for Bax,
CYP1A1, and cytokeratin 8/18. Triple-label
immunofluorescence for Bax, CYP1A1, and
cytokeratin 8/18 localizes the expression of Bax
and CYP1A1 in alveolar type II cells (alveolar
type II cells contain abundant cytokeratin 8 and
cytokeratin 18). We simultaneously applied
polyclonal antibodies for Bax (rabbit anti-Bax;
Santa Cruz Biotechnology), CYP1A1 (goat
anti-CYP1A1; Santa Cruz Biotechnology), and
cytokeratin 8/18 (guinea pig anti-cytokeratin
8/18; Research Diagnostics, Flanders, NJ) at
dilutions of 1:20, 1:10, and 1:5, respectively,
and incubated the slides overnight in a humidi-
fied chamber at room temperature followed by
2 hr at 37°C. The slides were then incubated
with a secondary antibody mixture containing
Alexa 594-conjugated donkey anti-rabbit IgG
(Molecular Probes), Alexa 350-conjugated
donkey anti-goat IgG (Molecular Probes), and
fluorescein isothiocyanate–labeled donkey anti-
guinea pig IgG (Research Diagnostics) anti-
bodies for detection of Bax, CYP1A1, and
cytokeratin 8/18, respectively. When viewed
with the fluorescent microscope, Bax appears
red, CYP1A1 appears blue, and cytokeratin
8/18 appears green.
Immunofluorescence digital imaging. We
examined the slides with an Olympus fluores-
cent photomicroscope (Olympus AX70;
Olympus American Inc., Lake Success, NY)
using three filters: green (460–500 nm excita-
tion), red (532.5–587.5 nm excitation) and
blue (460–500 nm excitation). For each emis-
sion wavelength, we photographed five images
from the proximal alveolar region, which are
alveoli located near the first alveolar ducts from
the terminal bronchioles, the alveolar region
most affected by particle deposition. We used a
Quantix digital camera (Quantix Photometrics,
Tucson, AZ) with QED camera plug-in soft-
ware (QED Imaging Inc., Pittsburgh, PA), and
held contrast, brightness and gamma settings
constant.
Quantifying Bax immunofluorescence. We
measured the area of Bax immunofluorescence
in the alveolar septum using a MetaMorph
Imaging System (Molecular Devices Corp.,
Downingtown, PA). In addition, we counted
the number of cells expressing Bax per 40×
field.
Triple-label immunofluorescence mor-
phometry. We used the MetaMorph Imaging
System to measure the area of alveolar tissue
labeled by fluorochromes indicating expression
of Bax (red), CYP1A1 (blue), and cytokeratin
8/18 (green). We also measured the co-locali-
zation of Bax, CYP1A1, and cytokeratin 8/18.
Proportional CYP1A1 expression in alveolar
type II cells corrected for particle-induced
increases in the cells and was the area of blue
fluorescence (representing CYP1A1) co-local-
ized with green (representing cytokeratin 8/18)
divided by the total green area. In each 40×
Ghanem et al.
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Table 1. The treatment groups, group size, and type of treatment in the caspase inhibitor study.
Group No. of rats IT exposure Caspase inhibitor (IP) PAH (IP)
1 6 Saline DMSO BNF
2 5 Saline Q-VD-OPH BNF
3 7 CD DMSO BNF
4 6 CD Q-VD-OPH BNF
microscopic field, we also counted the number
of alveolar type II cells expressing Bax (red
cells) and the number of alveolar type II cells
expressing both CYP1A1 and Bax.
TUNEL assay. We conducted terminal
deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) as previously
described (Gavrieli et al. 1992) using a
TUNEL assay kit (Promega, Madison, WI).
Briefly, we incubated deparaffinized slides with
the terminal deoxynucleotidyl transferase
enzyme and the nucleotide mix. We applied
propidium iodide as a counterstain. For a posi-
tive control, we incubated slides with DNase 1
(Sigma-Aldrich) and for a negative control, we
incubated slides without the terminal deoxynu-
cleotidyl transferase enzyme.
Histopathology. A board-certified veteri-
nary pathologist (A.F.H.) evaluated the lung
sections while blinded to the exposure status.
Histopathologic changes were semiquantita-
tively scored on a scale ranging from 0 to 5
for both severity and distribution to produce
a sum pathology score of 0 to 10 for each
slide (Hubbs et al. 1997).
Statistics. We analyzed data using SAS/
STAT software (version 8.2 of SAS System
for Windows; SAS Institute Inc., Cary, NC).
For Bax area and Bax-labeled cells per field,
we used the Proc Reg procedure. We analyzed
variables in the CD response study with a one-
factor analysis of variance (ANOVA) using the
Proc Mixed procedure. We analyzed effects of
the caspase inhibitor using a two-factor
ANOVA and compared different alveolar
regions using a three-factor split-unit ANOVA
using Proc Mixed. We used Fisher’s least sig-
nificant difference test for all post hoc pairwise
comparisons. We used the nonparametric
Kruskal-Wallis test followed by the Wilcoxon
rank-sum test for pairwise comparisons of
pathology scores. All results were considered
statistically significant at p ≤ 0.05.
Results
Effect of CD exposures on alveolar Bax expres-
sion. In the proximal alveolar region, CD
increased the area of Bax expression in a dose-
dependent manner (r 2 = 0.6541, p ≤ 0.001)
(Figure 1A; Supplemental Figure 1; available
online at http://www.ehponline.org/docs/2006/
8906/suppl.pdf). In addition, the average num-
ber of lung cells expressing Bax in the proximal
alveolar region was increased in a dose-depen-
dent fashion by CD exposure (r 2 = 0.903,
p ≤ 0.001) (Figure 1B; Supplemental Material,
Figure 1, available online at http://www.
ehponline.org/docs/2006/8906/suppl.pdf).
Relationship between Bax expression and
CYP1A1 induction in CD-exposed rats. In rats
exposed to BNF, CYP1A1 was strongly
expressed (Figure 2A); however, CD exposure
decreased BNF-induced CYP1A1 expression
(Figure 2B). In rats exposed to BNF alone, Bax
was rarely expressed (Figure 2C), but it was fre-
quently expressed in alveolar cells from rats
exposed to CD and BNF (Figure 2D). Small
numbers of cytokeratin 8/18–containing alveo-
lar type II cells were observed in rats exposed to
BNF alone (Figure 2E). CD increased the size
and number of alveolar type II cells in BNF-
exposed rats (Figure 2F).
The percentage of alveolar type II cells
coexpressing Bax was marginally increased
Coal dust increases pulmonary apoptosis
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Figure 1. Quantification (mean ± SE) of Bax expression in the proximal alveolar region with increasing CD
exposure in BNF-exposed rats. (A) Area of Bax expression. (B) The number of cells positive for Bax.
*Significantly different from saline/BNF (p ≤ 0.05). 
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Figure 2. Triple-label immunofluorescence for CYP1A1, Bax, and cytokeratin 8/18 in the BNF-exposed pul-
monary alveolus in response to CD exposure. (A) CYP1A1 expression in a BNF-exposed rat. (B) CYP1A1
expression in a rat exposed to CD and BNF. (C) Bax expression in a BNF-exposed rat. (D) Increased Bax
expression in a CD- and BNF-exposed rat. (E) Expression of cytokeratin 8/18 (alveolar type II cell marker) in a
BNF-exposed rat. (F) Increased expression of cytokeratin 8/18 in a BNF- and CD-exposed rat. Blue fluores-
cence indicates CYP1A1, red indicates Bax, and green indicates cytokeratin 8/18; bars = 20 µm. (G) The per-
centage of alveolar type II cells expressing Bax is increased by CD exposure. (H) The percentage of alveolar
type II cells expressing both Bax and CYP1A1 is decreased by CD exposure. Values shown are mean ± SE.
*Significantly different from saline/BNF (p ≤ 0.05).
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(p = 0.052) with CD exposure (Figure 2G;
Supplemental Material, Figure 2; available
online at http://www.ehponline.org/docs/2006/
8906/suppl.pdf). The percentage of alveolar
type II cells that concomitantly expressed both
Bax and CYP1A1 was significantly decreased
(p = 0.02) with increasing CD exposure
(Figure 2H; Supplemental Material, Figure 2;
available online at http://www.ehponline.org/
docs/2006/8906/suppl.pdf), suggesting an
inverse relationship between CYP1A1 induc-
tion and Bax expression in alveolar type II cells.
Effect of caspase inhibition on proximal
alveolar region Bax expression in CD-exposed
rats. In rats exposed to both CD and BNF,
Q-VD-OPH significantly reduced the area of
Bax expression (p < 0.001) (Figure 3A–E)
and the number of cells expressing Bax per
field (p = 0.001) (Figure 3A–D,F). However,
in BNF-exposed rats, Q-VD-OPH did not
completely eliminate CD-associated increases
in Bax expression (Figure 3D–F); the area of
Bax expression (Figure 3E) and the number
of cells expressing Bax per field (Figure 3F)
were significantly increased by CD exposure
(p = 0.005 and p ≤ 0.001, respectively) despite
Q-VD-OPH treatment.
Effect of CD on induced CYP1A1
immunofluorescence: role of caspases. We
evaluated the effect of CD on PAH-induced
CYP1A1 within alveoli in rats exposed to
BNF (the model PAH) in the alveolar region
of the lung most affected by particle deposi-
tion, the proximal alveolar region. Within
alveolar septa stained for both CYP1A1 and
cytokeratin 8/18, the area of BNF-induced
CYP1A1 expression localized to cells without
the alveolar type II markers (cytokeratin 8/18)
was significantly reduced (p ≤ 0.001) by CD
exposure (Figure 4A; Supplemental Material,
Figure 3; available online at http://www.
ehponline.org/docs/2006/8906/suppl.pdf). In
addition, the proportional CYP1A1 expression
in alveolar type II cells was significantly
reduced (p = 0.0028) by CD exposure in
BNF-injected rats (Figure 4B; Supplemental
Figure 3, available online at http://www.
ehponline.org/docs/2006/8906/suppl.pdf).
Q-VD-OPH did not significantly affect
CYP1A1 immunofluorescence in the alveolus
of rats exposed to BNF or to BNF and CD
(Figure 4).
Effect of caspase inhibition on CD-
induced apoptosis and morphologic altera-
tions in BNF-exposed rats. Histopathologic
Ghanem et al.
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Figure 3. Immunofluorescent staining showing suppression of Bax expression by Q-VD-OPH in the proximal
alveolar region of rats receiving (A) saline/BNF/DMSO, (B) saline/BNF/caspase inhibitor, (C) CD/BNF/DMSO,
or (D) CD/BNF/caspase inhibitor. Bars = 20 µm. (E) Bax expression area localized to alveolar type II cells.
(F) The number of Bax-expressing cells. Values shown are mean ± SE.
*Significantly different from saline/BNF (p ≤ 0.05). **Significantly different from corresponding rats not receiving Q-VD-OPH.
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Figure 4. CYP1A1 immunofluorescence (mean ± SE)
in the alveolar region of BNF-induced rats exposed
to CD with and without pan-caspase inhibition by
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alterations associated with CD exposure in
BNF-treated rats included histiocytic and
suppurative alveolitis with accumulation of
dark brown particles within the cytoplasm of
many alveolar macrophages, and alveolar
epithelial cell hypertrophy and hyperplasia
(Figure 5A). Caspase inhibition did not sig-
nificantly affect these histopathologic changes
of CD- and BNF-exposed rats (Figure 5B,E).
We did not observe histopathologic changes
in the lungs of rats instilled IT with vehicle
control and injected with BNF or BNF and
Q-VD-OPH. However, CD exposure signifi-
cantly increased the percentage of apoptotic
cells (p ≤ 0.048; Figure 5C) in the proximal
alveolar region, whereas caspase inhibition
with Q-VD-OPH significantly decreased the
percentage of apoptotic cells in the proximal
alveolar region of the CD-exposed rats
(p = 0.013; Figure 5D,F). The proximal
alveolar region had a higher percentage of
apoptotic cells than did random alveolar
regions from rats with the same exposures
(p = 0.013, p ≤ 0.001, p = 0.025, and p < 0.001
for saline/BNF/DMSO, CD/BNF/DMSO,
saline/BNF/inhibitor, and CD/BNF/inhibitor,
respectively; Figure 5F).
Effect of caspase inhibition on EROD and
PROD. Two forms of CYP were selected for
evaluation, the PAH-inducible CYP1A1 and
the major constitutive isoform of the rat lung,
CYP2B1. To determine if Bax expression or
apoptosis inhibited the activity of CYP1A1- or
CYP2B1-dependent reactions, we measured
pulmonary EROD and PROD activity. BNF-
induced EROD activity was significantly
reduced (p ≤ 0.05) in CD-exposed rats but
unaffected by the pan-caspase inhibitor
Q-VD-OPH (Figure 6A). Also, CD signifi-
cantly reduced PROD activity in BNF-treated
rats, and this effect persisted when caspases
were inhibited by Q-VD-OPH (Figure 6B).
Effect of caspase inhibition on CYP1A1
and CYP2B1 Western blots. CD exposure sig-
nificantly reduced the amount of CYP1A1
protein in the lungs of BNF-exposed rats
(p ≤ 0.05; Figure 7), but the amount of
CYP1A1 protein was unaffected by caspase
inhibition with Q-VD-OPH (Figure 7).
Similarly, the amount of CYP2B1 was not sig-
nificantly affected by caspase inhibition with
Q-VD-OPH (data not shown).
Discussion
High tissue concentrations of respirable CD
accumulate in the human lung in coal miners.
For example, in an autopsy study, the actual
measured dust burden (mean ± SD) in the
lung of nonsmoking coal miners was 16.4 ±
8.5 g (Kuempel et al. 2001). However, most
epidemiologic studies indicate no increased
risk of lung cancer in coal miners (Kuempel
et al. 1995). A potential difficulty in interpret-
ing the human lung cancer epidemiology
studies of CD is the potential confounding
from exposure to tobacco, a known lung car-
cinogen that contains abundant PAHs. This is
extremely important in coal miners because in
studies where smoking status is known, most
coal miners are smokers (Vallyathan et al.
1985). In addition, diesel engine exhaust and
other sources of PAHs are present within coal
mines. In our study, we have confirmed our
previous finding that in mixed exposures to
Figure 5. Morphologic features of caspase inhibition in CD-exposed pulmonary alveolus. (A,B) Lung photo-
micrographs demonstrating dust-laden macrophages in alveolar spaces (yellow arrows) and in the intersti-
tium (blue arrows), with hypertrophy and hyperplasia of alveolar type II cells (arrowheads) from (A) a
CD-exposed rat (CD/BNF/DMSO) and (B) a CD-exposed rat following caspase inhibition (CD/BNF/inhibitor).
(C,D) TUNEL assay showing green fluorescent apoptotic cells (arrows) in (C) a CD-exposed rat
(CD/BNF/DMSO) and (D) a CD-exposed rat after caspase inhibition (CD/BNF/inhibitor); note the decreased
number of apoptotic cells compared with (C). Bars = 20 µm. (E) Semiquantitative histopathology scores with
no evidence that caspase inhibition modifies CD-induced alveolitis or alveolar epithelial cell hypertrophy
and hyperplasia. (F) Apoptosis in BNF-treated rats exposed to IT CD with and without caspase inhibition.
Apoptosis is significantly higher in the proximal alveolar (PA) region when compared with random alveolar
(RA) regions. CD significantly increased apoptosis; caspase inhibition significantly decreased, but did not
entirely abrogate, CD-induced apoptosis. Values shown are mean ± SE.
*Significantly different from random alveolar region (p ≤ 0.05). **Significantly different from corresponding rats not
receiving CD. ***Significantly different from corresponding rats not receiving Q-VD-OPH.
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CD and PAHs, CD appears to modify PAH
metabolism by inhibiting CYP1A1 induction
(Ghanem et al. 2004). In the present study,
we also found that CD, like many other
agents that cause chronic pulmonary inflam-
mation and fibrosis, increases pulmonary
apoptosis and increases expression of the pro-
apoptotic mediator Bax. Previous studies sug-
gest that apoptosis plays a role in the
pathogenesis of a diverse group of fibrosing
lung diseases, including diffuse alveolar dam-
age, idiopathic pulmonary fibrosis (Kuwano
et al. 1999), and silicosis (Borges et al. 2002).
In this study, we demonstrate for the first
time that in vivo treatment with the pan-
caspase inhibitor Q-VD-OPH significantly
decreases apoptosis and Bax expression in the
lung. Because caspases are mediators of apopto-
sis, decreased apoptosis is an expected result of
caspase inhibition (Caserta et al. 2003).
Although somewhat unexpected, caspase inhi-
bition of Bax expression in our study suggests
that caspases play a role in Bax expression in
this model. Importantly, immunohistochemical
detection of Bax expression in lung correlates
well with apoptosis and the expression of other
apoptosis mediators (Kuwano et al. 2000;
Plataki et al. 2005). However, the relationship
between increased Bax expression in tissue sec-
tions and Bax activation has not been investi-
gated thoroughly.
CD-associated histopathologic alterations,
such as alveolitis and alveolar epithelial cell
hypertrophy and hyperplasia, were unaffected
by caspase inhibition and decreased apoptosis.
Other pan-caspase inhibitors, such as
N-benzyloxy-carbonyl-Val-Ala-Asp-(O-
methyl)-fluoromethyl ketone and BOC-Asp-
(O-methyl)-fluoromethyl ketone, have been
reported to reduce neutrophil accumulation in
the lungs of silicotic mice by 50% (Borges
et al. 2002). However, in the present study,
the principally histiocytic inflammatory reac-
tion in the lungs of CD-exposed rats was not
significantly suppressed by the injection of
Q-VD-OPH. Because the histopathologic
changes associated with silica exposure involve
more neutrophils and are more proliferative
than CD-induced pulmonary injury (Green
2000; Kuempel et al. 2003), these morpho-
logic differences may influence the ability to
attenuate silicotic injury through apoptosis
inhibition. It may also be that the role of
apoptosis in CD- and PAH-induced lung
injury is similar to the role of apoptosis in oxy-
gen toxicity, where apoptosis contributes to
cell death but caspase inhibition does not sig-
nificantly alter alveolar damage (Barazzone
et al. 1998). Alternatively, Bax expression and
apoptosis in the CD- and PAH-exposed lung
may be involved in resolution of lung injury,
as has been suggested in the lipopolysaccha-
ride-exposed lung (Wang et al. 2002).
The present study clearly indicates that
apoptosis is not a major contributor to early
morphologic injury in the CD- and PAH-
exposed rat lung. Changes in cellular mediators
or signaling cascades that produce Bax activa-
tion and increase apoptosis may have a role in
CYP down-regulation. Potential candidates
would include mediators of particle-induced
inflammation including p53, nitric oxide,
nuclear factor-κB (NF-κB), and/or initiators of
alveolar epithelial proliferation. Indeed, in vitro
studies indicate down-regulation of CYP1A1
induction by tumor necrosis factor α and acti-
vated NF-κB (Tian et al. 2003).
In summary, our findings indicate that, in
mixed exposures to CD and PAHs, CD
modifies important processes associated with
the pulmonary response to xenobiotics,
notably down-regulating xenobiotic metabo-
lism and increasing apoptosis. However, our
findings do not support the hypothesis that
apoptosis plays a critical role in early lung
injury and the down-regulation of CYP1A1
induction in mixed exposures to CD and
PAHs. Therefore, suppression of CYP2B1
and inducible CYP1A1 following CD and
PAH exposure is associated with, but not
caused by, up-regulation of Bax expression
and apoptosis of alveolar cells.
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exposed to BNF, CD, and caspase inhibitor; lane 13 is from a rat exposed to both CD and BNF, and lane 14 is
the molecular weight marker. (B) Densitometry values (mean ± SE).
*Significantly different from rats not exposed to CD (p ≤ 0.05).
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